Whole-exome sequencing studies have identified several deleterious de novo mutations in TRIO in different cohorts of individuals with neurodevelopmental disorders, including intellectual disability (ID) and/or autism spectrum disorders (ASD).16, 17, 18, 19 In addition, TRIO has been reported as intolerant to functional genetic variation.20 The gene discussed is TRIO; the disease is neurodevelopmental disorder.